Hi Antonio, Thanks for your comment, and congratulations on your incredible progress
While the complete results of the study have not yet been published, an initial press release in 2024 indicated that tirzepatide reduced the relative risk for the composite endpoint (HF urgent visit or hospitalization, oral diuretic intensification, or cardiovascular death) by 38%
These advances indicate a broadening scope for GLP-1 therapies across metabolic, renal, neurological and behavioral health domains
Protein-rich foods provide another powerful stimulus for GLP-1 secretion
Key Takeaway: Quality control is not just about performance
L-citrulline is a nonessential amino acid, meaning the body already makes it naturally